MoonLake Immunotherapeutics
MLTX
#5932
Rank
S$1.31 B
Marketcap
S$18.57
Share price
-1.44%
Change (1 day)
-73.73%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -S$0.28 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.18 Billion a decrease over its 2023 earnings that were of -S$70.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.28 Billion62.96%
2024 -S$0.18 Billion142.55%
2023 -S$70.11 Million-16.81%
2022 -S$84.28 Million